HIVE Digital Technologies Mines 112 Bitcoins in August-February 2024-www.financetom.com

HIVE Digital Technologies Mines 112 Bitcoins in August

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

HIVE Digital Technologies Mines 112 Bitcoins in August

Sep 5, 2024 5:43 PM

03:58 AM EDT, 09/05/2024 (MT Newswires) -- HIVE Digital Technologies ( HIVE ) said Thursday it mined 112 bitcoins in August.

The cryptocurrency miner said previously that it mined 116 bitcoins in July.

HIVE said it maintained an average mining capacity of over 5.0 exahash per second for August.

Additionally, HIVE said it increased its holdings to 2,533 bitcoins as of the end of August.

Price: 2.9499, Change: +0.15, Percent Change: +5.35

Previous page： BRIEF-Linqto Says Preparing A Registration Statement To File For A Potential IPO Listing On Nasdaq Next page： Asset manager TPG close to buying Germany's Techem for $7.8 bln, Financial Times reports

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

BRIEF-Linqto Says Preparing A Registration Statement To File For A Potential IPO Listing On Nasdaq

Oct 2, 2024

Sept 30 (Reuters) - Linqto: * LINQTO: PREPARING A REGISTRATION STATEMENT TO FILE FOR A POTENTIAL IPO LISTING ON NASDAQ Source text for Eikon: ...

Asset manager TPG close to buying Germany's Techem for $7.8 bln, Financial Times reports

Oct 2, 2024

Sept 30 (Reuters) - U.S.-based asset manager TPG is close to finalizing a 7 billion euro ($7.80 billion) deal to acquire German metering firm Techem, the Financial Times reported on Monday, citing people familiar with the matter. TPG may reach an agreement to acquire Techem from Switzerland's Partners Group as soon as Monday, FT added. ($1 = 0.8977 euros) ...

Annovis Bio Files Patents for Combination Therapies Using Buntanetap

Oct 2, 2024

02:21 PM EDT, 09/30/2024 (MT Newswires) -- Annovis Bio ( ANVS ) said Monday it filed three new patents for combination therapies involving its lead compound buntanetap with Trulicity or Viagra, or both. The therapies aim to treat neurodegenerative diseases, including Alzheimer's and Parkinson's, the company said, adding that early data shows potential cognitive improvement in preclinical studies using these...

US Judge Dismisses $6.4 Billion Suit Against Bristol Myers Over Delay in Drug Approvals

Oct 2, 2024

02:26 PM EDT, 09/30/2024 (MT Newswires) -- Bristol-Myers Squibb Company ( BMY ) won a dismissal of a $6.4 billion lawsuit alleging it delayed a Federal Drug Administration approval process for a Celgene drug in order to avoid paying Celgene shareholders for meeting certain milestones. As part of its deal to acquire Celgene, Bristol-Myers Squibb ( BMY ) issued Celgene...